Literature DB >> 11344523

IgA antibodies against endomysium and transglutaminase: a comparison of methods.

T D Jaskowski1, C Schroder, T B Martins, C M Litwin, H R Hill.   

Abstract

Recently, the endomysial antigen has been identified as the protein cross-linking enzyme known as tissue transglutaminase (tTG). Our objective was to compare a novel enzyme immunoassay (EIA) that detects IgA antibody against tTG to two standard IFA methods utilizing thin tissue sections of rat kidney/rat stomach (KS) and distal primate esophagus (PE) as substrates to detect IgA antibody against endomysium (EMA). Sera from 100 patients suspected of having gluten-sensitive enteropathy (GSE) and 23 sera possessing various antibodies used for EIA cross-reactivity studies were included. Additional tests, performed routinely in our laboratory, were utilized to further assess sera from patients suspected having GSE. These tests include anti-gliadin IgA antibody (AGA) and anti-reticulin IgA antibody (ARA) and are part of the European Society for Pediatric Gastroenterology and Nutrition (ESPGAN) revised criteria for diagnosing GSE. When compared to IFA using KS, the tTG EIA had a sensitivity of 87.5%, was 97.1% specific, and had an overall agreement of 94.0%. When compared to IFA using PE, the tTG EIA had a sensitivity of 92.6%, was 93.2% specific, and had an overall agreement of 93.0%. When the KS IFA was compared to the PE IFA for EMA, the KS IFA had a sensitivity of 96.3%, was 91.8% specific, and had an overall agreement of 93.0%. The majority of sera that were positive for tTG but were negative by IFA (KS, n = 2/PE, n = 5) possessed IgA antibodies against gliadin and/or reticulin. Five of six sera with negative results by PE IFA were positive by the KS IFA and possessed one or more antibodies to tTG and/or gliadin and/or reticulin. We conclude that the tTG EIA compares well to both KS and PE IFAs when detecting IgA antibody against endomysium. We do not recommend the use of PE to detect EMA primarily because of the inconsistencies (i.e., tissue selection, quality, and preparation) and limited availability of commercially prepared PE tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344523      PMCID: PMC6807754          DOI: 10.1002/jcla.1011

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  IgA antiendomysial antibody test. A step forward in celiac disease screening.

Authors:  U Volta; N Molinaro; M Fusconi; F Cassani; F B Bianchi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease.

Authors:  R Troncone; F Maurano; M Rossi; M Micillo; L Greco; R Auricchio; G Salerno; F Salvatore; L Sacchetti
Journal:  J Pediatr       Date:  1999-02       Impact factor: 4.406

3.  Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults.

Authors:  T Valdimarsson; L Franzen; E Grodzinsky; T Skogh; M Ström
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

4.  IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; J Sulej; H Tchorzewska; S Jablonska; E H Beutner; V Kumar
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

5.  Anti-transglutaminase antibodies and coeliac disease.

Authors:  A Miller; W Paspaliaris; P R Elliott; A d'Apice
Journal:  Aust N Z J Med       Date:  1999-04

6.  Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.

Authors:  W Dieterich; E Laag; L Bruckner-Tuderman; T Reunala; S Kárpáti; T Zágoni; E O Riecken; D Schuppan
Journal:  J Invest Dermatol       Date:  1999-07       Impact factor: 8.551

7.  Correlation between IgA antiendomysial antibodies and subtotal villous atrophy in dermatitis herpetiformis.

Authors:  U Volta; N Molinaro; R De Franchis; L Forzenigo; M Landoni; D Fratangelo; F B Bianchi
Journal:  J Clin Gastroenterol       Date:  1992-06       Impact factor: 3.062

8.  IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

9.  Autoantibodies to tissue transglutaminase as predictors of celiac disease.

Authors:  W Dieterich; E Laag; H Schöpper; U Volta; A Ferguson; H Gillett; E O Riecken; D Schuppan
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

10.  IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients.

Authors:  E Grodzinsky; J Hed; T Skogh
Journal:  Allergy       Date:  1994-09       Impact factor: 13.146

View more
  3 in total

Review 1.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 2.  Commentary: advances in the laboratory diagnosis of celiac disease.

Authors:  R A McPherson
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

3.  A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits.

Authors:  R C W Wong; R J Wilson; R H Steele; G Radford-Smith; S Adelstein
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.